A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer
暂无分享,去创建一个
G. Giaccone | M. Tan | Stephen V. Liu | G. Esposito | Deepa S. Subramaniam | Vincent Chen | T. Torres | J. Thompson | J. Crawford | C. Kim